USF Health’s IDPodcasts

Melissa Albert, Infectious Diseases Pharmacist at the James A Haley Veterans Hospital, discusses the recent new literature regarding changes in the clinical breakpoints. Utilizing clinical cases, Dr. Albert demonstrates how to interpret antimicrobial susceptibility reports as well as how to design a patient-centered treatment regimen. Dr. Albert also discusses inducible AmpC-E resistance and how specific breakpoints have been cha...

Dr. Shylah Moore-Pardo, Assistant Professor with the Division of Infectious Diseases and International Medicine, reviews the basics regarding vaccinations in the HIV-positive population. Dr. Pardo first reviews routine immunizations, such as Influenza, Tetanus, and COVID-19. She then covers risk specific vaccines, such as shots for Hepatitis B and C, meningococcus, and Mpox. Next, Dr. Pardo discusses routine vaccines indicated bas...

Dr. Lauren Rybolt, Infectious Diseases Fellow at the Division of Infectious Diseases, Morsani College of Medicine, discusses the ways that climate change is expected to alter the infectious diseases landscape. Dr. Rybolt begins her talk with the discussion of vector-borne diseases, and then goes on to discuss zoonotic infections, water-borne diseases, habitat changes, and natural disaster impacts. Lastly, Dr. Rybolt completes her ...

Dr. Guy Handley, Assistant Professor of Medicine with the Division of Infectious Diseases, USF Morsani College of Medicine, provides an overview of Human Herpesvirus 6 in Stem Cell Transplant Patients. Dr. Handley uses clinical cases to describe several scenarios related to HHV6 infection. Topics discussed include background, HHV6 latency, reactivation, clinical presentation, encephalitis, treatment strategies, and outcomes. Guide...

In a lively case-based format, Dr. Jackie Sherbuk, Assistant Professor of Medicine at the Division of Infectious Diseases, Moroni College of Medicine at USF, reviews important opportunistic infections (OI’s) in HIV/AIDS patients. Included in the talk, Dr. Sherbuk discusses effective timing of antiretrovirals in the setting of an opportunistic infection. She addresses HIV associated pulmonary disease, cerebral Toxoplasmosis, C...

Dr. Jamie Morano, Professor of Medicine at the Division of Infectious Diseases, USF Morsani College of Medicine, reviews the epidemiology of Tuberculosis and its relationship to Human Immunodeficiency Virus infection. Topics discussed include TB trends in the US, factors contributing to an increase in TB morbidity, tuberculosis transmission, TB screening, and progression to active disease. Next, Dr. Morano outlines the relationship...

Dr Guy Handley, Assistant Professor of Medicine at the Division of Infectious Diseases, Morsani College of Medicine, discusses the Clinical manifestations of Pneumocystis Jirovecii infections in a question and answer format. Dr. Handley begins the talk by giving an overview of Pneumocystis, including its history and taxonomy. He then discusses the typical presentation when it causes pneumonia (PCP), the most likely clinical manifes...

Dr. Jackie Sherbuk, Assistant Professor of Medicine at the Morsani College of Medicine Division of Infectious Diseases, presents this case-based review of the use of antiretroviral therapy in HIV/AIDS patients. Dr. Sherbuk begins by reviewing and available antireturovial options, including those that are considered first line. She also covers the use of antiretrovirals in special groups, including expectant mothers, elite controlle...

Jessica Kennedy, MD, Infectious Diseases Fellow at the University of South Florida Division of Infectious Diseases, discusses the scientific basics around many of the primary Infectious Diseases tests ordered by providers. Dr. Kennedy discusses the scientific basis for EIA/ELIZA, Quantiferon, chemiluminant immunoassays, lateral flow assays, RT-PCR, Fungitell, and LC/MS-MS. In explaining these diagnostic assays, Dr. Kennedy helps t...

Dr. Arun Sunny, Infectious Diseases Senior Fellow at the University of South Florida Division of Infectious Diseases, presents a second overview of the current infectious diseases literature focusing on studies that may influence your medical practice. Dr. Sunny focuses on the areas of climate change, prophylaxis, antimicrobial stewardship, and the use of AI (Artificial Intelligence) in medicine. From a talk originally presented in...

Dr. John Sia, Infectious Diseases Fellow at the University of South Florida Morsani College of Medicine, looks at the field of Infectious Diseases Medicine, and its prospects for continued success in recruitment and the economics of practice. Dr. Sia looks at some of the challenges for the infectious Diseases clinician, what ID needs to do to continue to attract some of the brightest and most talented medical professionals to the f...

Dr. Diaz Vera, Infectious Diseases Fellow at the University of South Florida Division of Infectious Diseases, presents a companion lecture to his original talk on bacteriophage therapy. Because of the rising tide of antimicrobial resistance, many experts believe that we are entering the post-antibiotic era in medicine. As a result, researchers are exploring phage-antimicrobial synergy in an attempt to make our antibiotic armamentar...

In the second of his two part series, Dr. John Toney reviews additional infectious syndromes involving the eye. For Part 2, Dr. Toney begins by discussing uveitis, and then covers preseptal and postseptal orbital cellulitis. Next he shares information on endogenous endophthalmitis and dacrocystitis. Finally, in a lightning round, trachoma, Parinaud’s oculoglandular syndrome, and Herpes Zoster ophthalmicus are presented. Fo...

In a two part series, Dr. John Toney, Professor of Medicine at the University of South Florida Division of Infectious Diseases, reviews various infectious syndromes involving the eye. For Part One, Dr. Toney initially reviews the anatomy of the eye. Next, he reviews blepharitis, conjunctivitis, and diseases of the cornea. Dr. Toney concludes the lecture by discussing microbial keratitis, HSV keratitis, and acanthamoeba keratitis. F...

Dr. Guy Handley, Assistant Professor at the USF Morsani Division of Infectious Diseases and International Medicine, presents a talk on Fungal pneumonias in immunocompromised patients. Dr. Handley begins by discussing the differential diagnosis of pneumonia, and then an overview of the most common types of mold pneumonias by pathogen. He then shares a case presentation of a mold pneumonia and discusses options in a question and answ...

Dr. Richard Oehler, Professor of Medicine at the Division of Infectious Diseases and International Medicine, Morsani College of Medicine at USF, presents this overview of Nocardia and Actinomyces, two closely-related gram positive filamentous rods which have distinct differences. In his presentation, Dr. Oehler initially covers Nocardiosis, followed by Actinomycosis, and compares and contrasts both and how they produce human infec...

Dr. Anthony Cannella, Associate Professor of Medicine at the University of South Florida Division of Infectious Diseases, presents this update on nontuberculous mycobacterial (NTM) infections. Dr. Cannella begins by discussing the taxonomy of nontuberculous mycobacteria. Next, he reviews epidemiology including the common methods of transmission of the infection. He then describes the immunological factors that confer increased susc...

Dr. Shuchi Pandya, infectious diseases clinician with the ID Associates of Tampa Bay, presents an update in the use of antimicrobials for surgical prophylaxis. Dr Pandyla begins by clarifying the definition of a surgical site infection. She then differentiates the categories of surgical procedures in terms of clean, clean contaminated, contaminated, and dirty procedures and their typical microbial characteristics. She then discusse...

Dr. Aliyah Baluch, Program Lead for Bone Marrow Transplant Infectious Diseases at Moffitt Cancer Center and Research Institute, reviews Important opportunistic fungal pathogens of relevance to the stem cell transplant and immunocompromised patient. Dr. Baluch beings by discussing the pharmacologic options for aspergillus treatment and their individual mechanisms of action. Next, through a case-based format, she reviews specific sce...